Table of Contents Table of Contents
Previous Page  796 860 Next Page
Information
Show Menu
Previous Page 796 860 Next Page
Page Background

intellectual challenges related to their dual roles of

researchers and clinicians. This role conflict may (uninten-

tionally) affect recruitment in a number ways, for example,

by creating difficulty conveying equipoise, discomfort with

the eligibility criteria, and exploring patient preferences.

Therefore, there is a need to develop training and support

programmes to enable recruiters to become more comfort-

able with the design and principles of RCTs. Donovan and

colleagues

[28]

state that this should include ensuring that

recruiters understand and can communicate key aspects of

the RCT design, and how to gently explore patients’

preferences. It has also been suggested that nurses and

doctors who recruit to RCTs require different training and

support. Doctors may benefit from support in relation to

assessments of eligibility and equipoise

[28] ,

whereas nurses

require support for perceived conflicts in their roles as a

recruiter, patient advocate, and clinician, and for helping

them to be comfortable with approaching all patients

[27]

.

Whilst common themes haven been identified in this

review, each RCT will have a set of unique issues that need

to be resolved. In urology RCTs, this may include lengthy

patient pathways, complex designs, and rapidly changing

treatment options. Only a small number of training

programmes have been developed from issues identified

by qualitative methods

[24,26,31,32,38,44,50,52]

. Most of

these have been QRIs

[24,26,31,32,44,50,52]

, which consist

of in-depth investigation of recruitment obstacles in real

time, followed by implementation of tailored strategies to

address these challenges as the trial proceeds. These

interventions have optimised practices that enable recruit-

ment to be completed in feasibility/pilot or main RCTs, or

have provided detailed evidence to support a decision to

cease recruitment. The multifaceted and flexible nature of

qualitative research can provide important insights into the

complexities of recruiting to trials so that subsequent

interventions can be developed, although quantitative

research would be more suited to rigorously evaluating

such programmes to determine the components that can

lead to improved recruitment and informed consent in

RCTs.

In summary, this article demonstrates that qualitative

research can provide important insights into the complexi-

ties of recruitment to trials, which can inform support and

training initiatives as required. Investigators should con-

sider implementing such methods in urological RCTs that

are expected to be challenging or are recruiting below target

to tackle the most challenging clinical questions facing

patients and clinicians.

Author contributions

: Daisy Elliott had full access to all the data in the study

and takes responsibility for the integrity of the data and the accuracy of the

data analysis.

Study concept and design

: Elliott, Donovan.

Acquisition of data

: Elliott.

Analysis and interpretation of data

: Elliott, Husbands, Donovan.

Drafting of the manuscript

: Elliott.

Critical revision of the manuscript for important intellectual content

: Elliott,

Husbands, Hamdy, Holmberg, Donovan.

Statistical analysis

: None.

Obtaining funding

: None.

Administrative, technical, or material support

: Elliott, Donovan.

Supervision

: Donovan.

Other

: None.

Financial disclosures:

Daisy Elliott certifies that all conflicts of interest,

including specific financial interests and relationships and affiliations

relevant to the subject matter or materials discussed in the manuscript

(eg, employment/affiliation, grants or funding, consultancies, honoraria,

stock ownership or options, expert testimony, royalties, or patents filed,

received, or pending), are the following: None.

Funding/Support and role of the sponsor:

None

[15_TD$DIFF]

.

Acknowledgments:

This work was supported by the Medical Research

Council (MRC) ConDuCT-II Hub (Collaboration and innovation for

Difficult and Complex randomized controlled Trials In Invasive

procedures – MR/K025643/1) and the Royal College of Surgeons of

England Bristol Surgical Trials Centre. JLD was supported by the NIHR

Collaboration for Leadership in Applied Health Research and Care

(CLAHRC) West at University Hospitals Bristol NHS Foundation Trust. JLD

and FCH are NIHR Senior Investigators This article presents independent

research funded by the MRC and NIHR. The views expressed are those of

the authors and not necessarily those of the MRC, NHS, NIHR or the

Department of Health. DE, SH and JLD are members of the QuinteT

research group.

Appendix A. Supplementary data

Supplementary data associated with this article can be

found, in the online version, at

http://dx.doi.org/10.1016/j. eururo.2017.04.036 .

References

[1]

Dahm P, Chapple CR, Konety BR, et al. The future of clinical practice guidelines in urology. Eur Urol 2011;60:72–4.

[2]

Borawski KM, Norris RD, Fesperman SF, Vieweg J, Preminger GM, Dahm P. Levels of evidence in the urological literature. J Urol 2007;178:1429–33.

[3]

Treweek S, Lockhart P, Pitkethly M, et al. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and meta-analysis. BMJ Open 2013;3:e002360.

[4]

Dahm P, N’Dow J, Holmberg L, Hamdy F. The future of randomised controlled trials in urology. Eur Urol 2014;66:1–3.

[5]

Wilt TJ, Brawer MK, Barry MJ, et al. The Prostate cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Pro- gram #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful wait- ing for men with clinically localized prostate cancer. Contemp Clin Trials 2009;30:81–7.

[6]

Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 2016;375:1425–37.

[7]

Hamdy FC, Donovan JL, Lane JA, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 2016;375:1415–24.

[8]

McDonald A, Knight R, Campbell M, et al. What influences recruit- ment to randomized controlled trials?. A review of trials funded by two UK funding agencies. Trials 2006;7:9.

[9]

Campbell MK, Snowdon C, Francis D, et al. Recruitment to random- ised trials: strategies for trial enrolment and participation study. The STEPS study. Health Technol Assess 2007;11: iii, ix-105.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 7 8 9 – 7 9 8

796